ClinicalTrials.gg
Not yet recruitingNCT06980441Updated May 20, 2025

Culturally Adapted Psychological Support for Conflict-Affected Afghans: Study Protocol on Mental Health & Violence

An interventional study of Problem Management Plus with Emotional Processing module in Depression and Suicide Ideation, Anxiety and PTSD, sponsored by Peace of Mind Association (PoMA). Not yet recruiting at 1 site in Afghanistan. Open to participants aged 16 Years to 30 Years. Per ClinicalTrials.gov, last updated 2025-05-20.

Sponsored by Peace of Mind Association (PoMA) · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
16 Years to 30 Years
Sex
All
01

Study summary

This pilot study examines the feasibility and acceptability of a culturally adapted psychological intervention-Problem Management Plus with Emotional Processing (PM+ EP)-for young Afghans aged 16-30 experiencing high psychological distress. Through a pilot randomized control trial and qualitative interviews, the study explores whether PM+ EP can reduce symptoms of anxiety, depression, PTSD, and aggression, and improve daily functioning. Findings will inform the potential for a larger trial and address critical mental health and violence prevention needs in conflict-affected Afghan communities.

Read the detailed description

Background: A large portion of Afghanistan's population, particularly children, has endured prolonged conflict, poverty, and displacement, leading to significant psychological distress. As children grow into adolescence and adulthood, this distress often manifests in mental health symptoms and an increased likelihood of violent behaviours. With limited mental health professionals and strong stigma around mental health in Afghanistan, culturally adapted, evidence-based interventions are needed.

Objective: The study aims to explore the feasibility and acceptability of culturally adapted mental health intervention Problem Management Plus with an additional Emotional Processing module (PM+ EP), in reducing psychological distress in young Afghans. The primary objective is to assess the feasibility of delivering this intervention in Afghanistan and its acceptability by the target communities, and the secondary objective is to assess symptom reduction and behavioural change.

Methods: This is a pilot Randomized Control Trial (RCT) with participants aged 16 to 30 in Afghanistan. Eligible participants, young Afghans with high levels of distress and impaired functioning - measured by the Kessler Psychological Distress Scale (K10) -, will be randomized to PM+ EP (n=30) or the waiting group (n=30). The participants will be evaluated through self-report questionnaires at three time points; baseline (T1), four weeks later immediately post-intervention (T2), and 3 months post-intervention (T3), and through a qualitative interview (Process Evaluation) at the end of the study. Outcomes will include measures of anxiety and depression (HSCL-25), aggressive behaviours (AGQ), PTSD symptoms (PCL-5), and daily functioning (WHODAS 2.0).

Analysis: This study will assess the feasibility and acceptability of culturally adapted PM+ EP in Afghanistan and explore the relationship between mental health symptoms and violence among young Afghans. It will be the first to evaluate the feasibility of PM+ EP with this population and could pave the way for a large define RCT examining the effectiveness this approach, should the results show promise.

02

Conditions studied

  • Depression and Suicide Ideation
  • Anxiety
  • PTSD

Keywords

  • Youth mental health
  • Afghanistan
  • Implementation science
  • Culturally adapted psychological support
  • Evidence informed interventions
  • Mental health symptoms
  • Psychological experiences
03

In context

Depression

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's planned enrollment of 60 is below the median of 81 across 7,063 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

This is the only study on the registry with Peace of Mind Association (PoMA) as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Psychological Distress, measured at >15 on the Kessler Psychological Distress Scale (K10)
  • Afghan nationality
  • Age between 16 and 30
  • Ability to read and write in Dari

Exclusion criteria

Exclusion Criteria:

  • Imminent suicide risk
  • Experiencing psychosis
  • Neurological or cognitive disabilities
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Intervention Arm: PM+ EP

    Participants in this group will receive a culturally adapted version of the World Health Organization's Problem Management Plus (PM+) program, with an added Emotional Processing (EP) module. The intervention will be delivered through six individual sessions over one month by trained Afghan facilitators of the same gender as the participant. Sessions will focus on managing distress, solving problems, building social support, and processing difficult emotions.

    Behavioral: Problem Management Plus with Emotional Processing module

  • No intervention
    No Intervention Arm

    Participants in this group will not receive the intervention during the study period but will complete the same assessments as the intervention group. After the study concludes, they will be offered the opportunity to receive the PM+ EP sessions.

Interventions

  • BehavioralProblem Management Plus with Emotional Processing module

    PM+ EP comprises of Problem Management Plus, an evidence-based low intensity psychological intervention developed by the World Health Organization (WHO), with an additional Emotional Processing module specifically to address psychological distress related to trauma exposure. The core of the intervention is designed for adults impaired by distress in communities exposed to conflict and adversity; it consists of CBT techniques that have been adapted for communities that do not have good availability of specialist care. The additional module was developed by researchers treating refugee youth (Alozkan Sever et al, 2021). For this study, PM+ EP will be a six-session individual and guided support program. The original sections of PM+ are available in many languages including Farsi, and the additional EP module will be translated by PoMA's Afghan translator. The sessions cover the topics of managing stress, strengthening social support, staying well and persevering.

06

What researchers measure

Primary outcomes

  1. Reduction in psychological distress symptoms among participants, as measured by scientific scale HSCL-25.

    In this pilot RCT, the primary outcome is to explore the feasibility and acceptability of delivering the PM+ EP intervention in Afghanistan. The study serves to demonstrate whether such interventions could be safety scaled and produce positive outcomes for the target population. All participants will complete four surveys for assessment at study points T0, T1, T2 and T3. The Hopkins Symptom Checklist 25 (HSCL-25) is one outcome measure designed to measure for anxiety and depression. Hopkins Symptom Checklist-25 (HSCL-25) is a 25 item self-report questionnaire assessing symptoms of psychological distress; 10 items for anxiety symptoms and 15 items for depression symptoms (2 of which identify somatic symptoms) (Mollica et al, 1987). The items are rated on a 4-point Likert scale, ranging from 1 (never) to 4 (always) with the anxiety scale ranging from 10-40 and the depression scale from 15-60. The total scale (range 25-100) represents psychological distress.

    Time frame: Pre-intervention until 3 months post-intervention

  2. Reduction in psychological distress symptoms among participants, as measured by scientific scale DSM-5 (PCL-5).

    The primary outcome of this pilot RCT is to assess the feasibility and acceptability of delivering the PM+ EP intervention in Afghanistan and its potential for safe scale-up and positive impact. All participants will complete four assessments at T0, T1, T2, and T3. PTSD symptoms will be measured using the PTSD Checklist for DSM-5 (PCL-5), a 20-item self-report tool that assesses symptoms over the past month. Each item is scored from 0 (Not at all) to 4 (Extremely), covering four symptom clusters: Re-experiencing, Avoidance, Negative Cognition/Mood, and Hyperarousal. A provisional PTSD diagnosis can be made if participants endorse the minimum number of symptoms in each cluster at a rating of 2 or higher. A total score between 31-33 suggests probable PTSD. This outcome will help determine whether PM+ EP is a feasible and acceptable approach to reducing trauma symptoms among conflict-affected youth in Afghanistan.

    Time frame: Pre-intervention until 3 months post-intervention

  3. Reduction in psychological distress symptoms among participants, as measured by scientific scale WHODAS 2.0.

    The primary outcome of this pilot RCT is to assess the feasibility and acceptability of delivering the PM+ EP intervention in Afghanistan, evaluating its potential for safe scale-up and positive outcomes. All participants will complete four assessments at T0, T1, T2, and T3. Functional ability will be measured using the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), a validated tool developed by WHO to assess health and disability across six domains: cognition, mobility, self-care, getting along, life activities, and participation. Participants report difficulties experienced in the past 30 days on a five-point Likert scale (1 = none to 5 = extreme), with total scores ranging from 12 to 60. Higher scores indicate greater functional impairment. This outcome will inform whether PM+ EP is feasible, acceptable, and functionally beneficial for young Afghans experiencing psychological distress.

    Time frame: Pre-intervention until 3 months post-intervention

Secondary outcomes

  1. Participant-Reported Changes in Attitudes Toward Violence and Perceived Impact of PM+ EP on Mental Health and Behavior.

    This outcome explores the relationship between mental health symptoms and violent behavior through qualitative interviews with a purposive sample of participants and facilitators conducted after the intervention (T3). Interviews will investigate perceived changes in psychological distress, aggressive behavior, and attitudes toward violence, as well as the cultural relevance and acceptability of the PM+ EP intervention. Data will be analyzed thematically using ATLAS.ti. Results will be used to illustrate context-specific linkages between mental health and violence and to inform future adaptation and scale-up of culturally tailored psychological interventions in conflict-affected settings.

    Time frame: 3 months post-intervention

  2. Analysis of relationship between mental health and violence, as measured by scientific scale AGQ.

    The study's secondary outcome is to examine the relationship between mental health and violence, and assess the potential impact of culturally adapted mental health programming on symptom and behavioral change, particularly in reducing violence. Aggression will be measured using the Aggression Questionnaire (AGQ), a 29-item self-report tool assessing physical aggression, verbal aggression, anger, and hostility. Participants rate each item on a 7-point Likert scale (1 = extremely uncharacteristic of me; 7 = extremely characteristic of me), with total scores ranging from 29 to 203. Higher scores indicate greater levels of aggression. The AGQ captures both aggressive acts and temperamental traits, allowing for analysis of change in aggressive behaviors and attitudes over time. This outcome will contribute to understanding context-specific linkages between mental health symptoms and violence in conflict-affected populations.

    Time frame: Pre-intervention until 3 months post-intervention

07

Study locations

1 site
  • Peace of Mind Association (PoMA)
    Kabul, Afghanistan
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Anonymised study data will be available upon request after publication.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: Data requests can be submitted immediately after article publication and the data will be made accessible for up to 24 months.

Access criteria: Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and the signing of a Data Sharing Agreement (DSA).

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2025; primary completion for Dec 2025, 6 months later.

Of 3,468 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 6 months is below that.

Counting every sponsor, half of 3,566 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
May 1, 2025
First posted
May 20, 2025
StartEst.
Jun 2025
Primary completionEst.
Dec 2025
CompletionEst.
Dec 2026
Last update
May 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06980441
Lead sponsor
Peace of Mind Association (PoMA)
Collaborators
VU University of Amsterdam
Responsible party
Lyla Schwartz (Directors of Programs and Psychology, Peace of Mind Association (PoMA)) — Principal investigator
First posted
May 20, 2025
Start date
Jun 2025 (estimated)
Primary completion
Dec 2025 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 20, 2025

Study contacts

Lyla L Schwartz, Masters
Contact
lyla@pomaglobal.org
4132973569
Lyla L Schwartz, Masters
principal investigator · Peace of Mind Association (PoMA)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion